Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study | Zendy

Franco Ferrario | Zendy; M. Barone | Zendy; Giovanni Landoni | Zendy; A. Genderini | Zendy; M. Heidemperger | Zendy; Matteo Trezzi | Zendy; Emanuela Piccaluga | Zendy; Paolo Danna | Zendy; D. Scorza | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study

Author(s) -

Franco Ferrario,

M. Barone,

Giovanni Landoni,

A. Genderini,

M. Heidemperger,

Matteo Trezzi,

Emanuela Piccaluga,

Paolo Danna,

D. Scorza

Publication year - 2009

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfp306

Subject(s) - medicine , nephropathy , creatinine , iodixanol , contrast induced nephropathy , urology , renal function , acetylcysteine , saline , gastroenterology , placebo , kidney disease , hemodialysis , surgery , anesthesia , contrast medium , endocrinology , pathology , diabetes mellitus , biochemistry , chemistry , alternative medicine , antioxidant , radiology

Intravenous administration of saline and non-ionic isosmolar contrast media significantly reduces the incidence of contrast-induced nephropathy, one of the most common causes of acute renal failure. Results with oral N-acetylcysteine are conflicting. The aim of our study was to evaluate the prophylactic role of N-acetylcysteine in patients with stable chronic renal failure undergoing coronary and/or peripheral angiography and/or angioplasty.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research